Literature DB >> 17649347

Six-Azauracil Treatment of Experimental Avian Lymphomatosis.

V L Sanger.   

Abstract

Entities:  

Year:  1962        PMID： 17649347      PMCID： PMC1583413     

Source DB:  PubMed          Journal:  Can J Comp Med Vet Sci        ISSN： 0316-5957


× No keyword cloud information.
  7 in total

1.  Studies on the pharmacology of 6-azauracil.

Authors:  A D WELCH; R E HANDSCHUMACHER; J J JAFFE
Journal:  J Pharmacol Exp Ther       Date:  1960-07       Impact factor: 4.030

2.  Evaluation of a new chemotherapeutic agent in patients with 'advanced refractory' acute leukemia. Studies of 6-azauracil.

Authors:  E J FREIREICH; E FREI; J F HOLLAND; D PINKEL; O SELAWRY; H ROTHBERG; F HAURANI; R TAYLOR; E A GEHAN
Journal:  Blood       Date:  1960-09       Impact factor: 22.113

3.  The anticancerous action of 6-azauracil (3, 5-dioxo-2, 3, 4, 5-tetrahydro-1, 2, 4-triazine).

Authors:  F SORM; A JAKUBOVIC; L SLECHTA
Journal:  Experientia       Date:  1956-07-15

4.  Further observations on the effect of aminopterin, a-methopterin and citrovorum factor on the growth of transplantable avian lymphoid tumours.

Authors:  L G CHUBB; A L LAURSEN
Journal:  Br J Pharmacol Chemother       Date:  1954-12

5.  Observations on the effect of triethylene melamine, aminopterin, and A-methopterin on the growth of transplantable avian lymphoid tumors.

Authors:  C le Q DARCEL
Journal:  Br J Pharmacol Chemother       Date:  1953-09

6.  Studies on the carcinostatic activity in mice of 6-azauracil riboside (azauridine), in comparison with that of 6-azauracil.

Authors:  J J JAFFE; R E HANDSCHUMACHER; A D WELCH
Journal:  Yale J Biol Med       Date:  1957-12

7.  Effects of various immune rabbit serums on the cells of several transplanted mouse lymphomas in vitro and in vivo; with special reference to inhibition by an antibody that reacts with neoplastic and non-neoplastic lymphocytic cells of mice.

Authors:  S C MOHOS; J G KIDD
Journal:  J Exp Med       Date:  1957-03-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.